Trials / Terminated
TerminatedNCT00380276
Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol
Open Label Study of the Effect of Daily Treatment With MPC-7869 in Subjects With Dementia of the Alzheimer's Type
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- Myrexis Inc. · Industry
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
Open-label treatment with MPC-7869 for participants in a previous randomized study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MPC-7869 | 800 mg BID Oral dosing |
Timeline
- Start date
- 2006-09-01
- Completion
- 2008-12-01
- First posted
- 2006-09-25
- Last updated
- 2008-08-05
Locations
90 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00380276. Inclusion in this directory is not an endorsement.